Cascade Bio
The University of Colorado Connection
Cascade Bio’s proprietary enzyme immobilization technology, dubbed “Body Armor,” acts as a cushion for the enzyme, enabling it to last longer, withstand more challenging conditions, and work across a wider operating window than other cell-free solutions. The technology was invented by co-founder while a graduate student in the CU ǸԹ laboratories of (CU ǸԹ Chemical and Biological Engineering) and (CU ǸԹ Chemical and Biological Engineering).
Funding Status and Investment Opportunities
- Industry Applications: Biotech, Manufacturing
- Funding Stage: Seed Round
- Contact for Investment Inquiries:Alex Rosay, alex@cascadebio.com
In the News
- Cascade Bio secures $6M to scale breakthrough biocatalysts (2025)
- CU ǸԹ hosts showcases highlighting breakthrough innovations and investment-ready ventures (2025)
- The Colorado Office of Economic Development and International Trade announces grants to CU researchers and startups (2024, OEDIT)
- 2023 Destination Startup drives investment in intermountain west university innovations (2023)
- Cascade Biocatalysts secures $2.6M to scale enzymes for biomanufacturing (2023, Business Wire)
Venture Partners Programs
This page was last updated on Dec. 5, 2025. Please contact vpnews@colorado.edu for corrections or updates
The Insider Investor eNewsletter
Media Inquiries
For marketing inquiries and news tips, contact Daniel Leonard,senior marketing and communications specialist for Venture Partners at CU ǸԹ.
For media inquiries, please visit .